Page 297 - Color_Atlas_of_Physiology_5th_Ed._-_A._Despopoulos_2003
P. 297

!
       and glycogenesis and suppresses those involved  poglycemia (e.g., due to fasting, prolonged
       in gluconeogenesis. Insulin also increases the  physical exercise; ! B) and sympathetic im-
       number of GLUT-4 uniporters in skeletal myo-  pulses (via ! 2 adrenoceptors; ! A). Glucagon
       cytes. All these actions serve to lower the  secretion is inhibited by glucose and SIH
       plasma glucose concentration (which in-  (! p. 273, B) as well as by high plasma concen-
       creases after food ingestion). About two-thirds  trations of free fatty acids.
       of the glucose absorbed by the intestines after  The actions of glucagon (! A, B, C) (via
       a meal (postprandial) is temporarily stored  cAMP; ! p. 274) mainly antagonize those of
       and kept ready for mobilization (via glucagon)  insulin. Glucagon maintains a normal blood
       during the interdigestive phase. This provides  glucose level between meals and during phases
    Hormones and Reproduction  bolism). In addition, it promotes growth, inhib-  and (b) by stimulating gluconeogenesis from
                                       of increased glucose consumption to ensure a
       a relatively constant supply of glucose for the
                                       constant energy supply. It does this (a) by in-
       glucose-dependent CNS and vital organs in ab-
       sence of food ingestion. Insulin increases the
                                       creasing glycogenolysis (in liver not muscle)
       storage of amino acids (AA) in the form of pro-
                                       lactate, AA (protein degradation = catabolism)
       teins, especially in the skeletal muscles (ana-
                                       and glycerol (from lipolysis).
       its extrahepatic lipolysis (! p. 257, D) and af-
                                       Increased plasma concentrations of amino acids
           +
       fects K distribution (! p. 180).
                                       (AA) stimulate insulin secretion which would lead to
                                       hypoglycemia without the simultaneous ingestion of
       tion is too high. Glucose levels of ! 2 mmol/L
                                       however, since AA also stimulate the release of
       (35 mg/dL) produce glucose deficiencies in the brain,
                                       glucagon, which increases the blood glucose con-
       which can lead to coma and hypoglycemic shock.
    11  Hypoglycemia develops when the insulin concentra-  glucose. Hypoglycemia normally does not occur,
                                       centration. Glucagon also stimulates gluconeogene-
         The excessive intake of carbohydrates can over-
       load glycogen stores. The liver therefore starts to  sis from AA, so some of the AA are used for energy
       convert glucose into fatty acids, which are trans-  production. In order to increase protein levels in
       ported to and stored in fatty tissues in the form of tri-  patients, glucose must therefore be administered
       acylglycerols (! p. 257 D).     simultaneously with therapeutic doses of AA to pre-
         Diabetes mellitus (DM). One type of DM is in-  vent their metabolic degradation.
       sulin-dependent diabetes mellitus (IDDM), or type 1
       DM, which is caused by an insulin deficiency. Another  Somatostatin (SIH). Like insulin, SIH stored in
       type is non-insulin-dependent DM (NIDDM), or type 2  D cells (SIH 14 has 14 AA) is released in re-
       DM, which is caused by the decreased efficacy of in-  sponse to increased plasma concentrations of
       sulin and sometimes occurs even in conjunction with  glucose and arginine (i.e., after a meal).
       increased insulin concentrations. DM is characterized  Through paracrine pathways (via G i-linked re-
       by an abnormally high plasma glucose concentration  ceptors), SIH inhibits the release of insulin
       (hyperglycemia), which leads to glucosuria (! p. 158).  (! p. 273, B). Therefore, SIH inhibits not only
       Large quantities of fatty acids are liberated since  the release of gastrin, which promotes diges-
       lipolysis is no longer inhibited (! p. 257 D). The fatty  tion (! p. 243, B3), but also interrupts the in-
       acids can be used to produce energy via acetyl-
       coenzyme A (acetyl-CoA); however, this leads to the  sulin-related storage of nutrients. SIH also in-
       formation of acetoacetic acid, acetone (ketosis), and  hibits glucagon secretion (! p. 273 B). This ef-
       !-oxybutyric acid (metabolic acidosis, ! p. 142). Be-  fect does not occur in the presence of a glucose
       cause hepatic fat synthesis is insulin-independent  deficiency because of the release of cate-
       and since so many fatty acids are available, the liver  cholamines that decrease SIH secretion.
       begins to store triacylglycerols, resulting in the  Somatotropin (STH) = growth hormone
       development of fatty liver.     (GH). The short-term effects of GH are similar
                                       to those of insulin; its action is mediated by so-
       Glucagon, Somatostatin and Somatotropin
       Glucagon released from A cells is a peptide  matomedins (! p. 280). In the long-term, GH
       hormone (29 AA) derived from proglucagon  increases the blood glucose concentration and
                                       promotes growth.
       (glicentin). The granules in which glucagon is
                                        The effects of glucocorticoids on carbohy-
       stored are secreted by exocytosis. Secretion is  drate metabolism are illustrated on plate C and
       stimulated by AA from digested proteins (es-
  284                                  explained on p. 296.
       pecially alanine and arginine) as well as by hy-
       Despopoulos, Color Atlas of Physiology © 2003 Thieme
       All rights reserved. Usage subject to terms and conditions of license.
   292   293   294   295   296   297   298   299   300   301   302